2021 Healthy China - The First China OTC Conference and China Traditional Chinese Medicine Promotion Conference was held in Guangzhou from October 18-21, 2021. During the conference, the "2021 China Non-prescription Drug Product Comprehensive Statistics Rankings" were released, where Lingrui Pharmaceutical ranked 25th; Six Lingrui products were included in the top 20 list of Chinese patent medicines in orthopedics and traumatology. These included the Meridian Obstruction Removing and Pain Relieving Plaster Patch (Bone Hyperostosis Relief Plaster), Musk Bone-strengthening and Pain-relieving Plaster Patch, Pain Relieving Plaster Patch for Injury and Rheumatism, Joint Pain-relieving Plaster Patch, Musk Bone-strengthening Plaster Patch and Pain-Relieving Tincture.
The China OTC Conference is a professional comprehensive forum for the pharmaceutical industry. It is hosted by the China Over-the-Counter Drug Association and co-hosted by Xinhuanet and the China National Brand Network.
As one of the leading companies in the field of orthopedic plasters in China, Lingrui Pharmaceutical always places their focus on common ailments of the Chinese people's bone and joints, such as the cervical spine, lumbar spine and knee joints. The featured product, the Meridian Obstruction Removing and Pain-Relieving Plaster Patch (Bone Hyperostosis Relief Plaster) is both an exclusive and nationally protected product of traditional Chinese medicine. Since its launch, it has garnered a trusted reputation with "phubbers" and patients with osteoarthropathy. It has been successively rated as one of the "Most Popular Rheumatology Orthopedic Medicines" and as a "Top Ten Brand of Chinese Patent Medicine in Orthopedics" by industry experts.
Lingrui Pharmaceutical always adheres to the corporate philosophy of " Sincerity and the benefit of mankind ". It strongly emphasizes the development of the medical and health industry and strives to continue leading the charge with innovation. It will continue to provide patients with a better experience and make greater contributions to the prosperity and development of OTC as well as to the healthcare industry.
